Prevention of coagulase-negative staphylococcal central venous catheter-related infection using urokinase rinses: A randomized double-blind controlled trial in patients with hematologic malignancies

Journal of Clinical Oncology

Volumn 26, Issue 3, 2008, Pages 428-433

  Van Rooden, Cornelis J ^a   Schippers, Emile F ^a   Guiot, Henri F L ^a   Barge, Renée M ^a   Hovens, Marcel M C ^a   Van Der Meer, Felix J M ^a   Rosendaal, Frits R ^a   Huisman, Menno V ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CIPROFLOXACIN; COTRIMOXAZOLE; NEOMYCIN; PIPEMIDIC ACID; PLACEBO; POLYMYXIN; UROKINASE;

ADULT; ALLERGY; ARTICLE; BACTERIUM CULTURE; BLEEDING; BRAIN HEMORRHAGE; CATHETER INFECTION; CLINICAL TRIAL; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; INFECTION RISK; INTRAVENOUS CATHETER; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STAPHYLOCOCCUS INFECTION; THROMBOCYTE COUNT; VEIN CATHETERIZATION;

ADULT; ANTICOAGULANTS; ANTINEOPLASTIC AGENTS; BONE MARROW TRANSPLANTATION; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; COAGULASE; DOUBLE-BLIND METHOD; FEMALE; FIBRINOLYTIC AGENTS; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; PLACEBOS; STAPHYLOCOCCAL INFECTIONS; STEM CELL TRANSPLANTATION; URINARY PLASMINOGEN ACTIVATOR; VENOUS THROMBOSIS;

EID: 38649090672     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.11.7754     Document Type: Article

References (22)

1. Ramphal R: Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens. Clin Infect Dis 39:S25-S31, 2004 (suppl 1)
2. O'Grady NP, Alexander M, Dellinger EP, et al: Guidelines for the prevention of intravascular catheter-related infections: Centers for Disease Control and Prevention. MMWR Recomm Rep 51:1-29, 2002
3. Centers for Disease Control and Prevention: Reduction in central line-associated bloodstream infections among patients in intensive care units-Pennsylvania, April 2001-March 2005. MMWR Morb Mortal Wkly Rep 54:1013-1016, 2005
4. Coyle VM, McMullan R, Morris TCM, et al: Catheter-related bloodstream infection in adult haematology patients: Catheter removal practice and outcome. J Hosp Infect 57:325-331
5. Mermel LA, McCormick RD, Springman SR, et al: The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: A prospective study utilizing molecular subtyping. Am J Med 91:S197-S205, 1991 (suppl)
6. Guiot HFL, Ballering HCM, van Gestel MH, et al: Epidemiology and clinical aspects of i.v. catheter-associated CNS infection: Evaluation of a typing system. Presented at 3rd International Conference of the Hospital Infection Society, London, United Kingdom, September 4-8, 1994
7. Raad II, Costerton W, Sabharwal U, et al: Ultrastructural analysis of indwelling vascular catheters: A quantitative relationship between luminal colonization and duration of placement. J Infect Dis 168:400-407, 1993
8. Linares J, Sitges-Serra A, Garau J, et al: Pathogenesis of catheter sepsis: A prospective study with quantitative and semiquantitative cultures of catheter hub and segments. J Clin Microbiol 21:357-360, 1985
9. Maki DG: Infections associated with intravascular lines, in Remington JS (ed): Current Clinical Topics in Infectious Diseases. New York, NY, McGraw-Hill, 1982, pp 309-363
10. Herrmann M, Vaudaux PE, Pittet D, et al: Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J Infect Dis 158:693-701, 1988
11. Vaudaux P, Pittet D, Haeberli A, et al: Host factors selectively increase staphylococcal adherence on inserted catheters: A role for fibronectin and fibrinogen or fibrin. J Infect Dis 160:865-875, 1989
12. Mehall JR, Saltzman DA, Jackson RJ, et al: Fibrin sheath enhances central venous catheter infection. Crit Care Med 30:908-912, 2002
13. Guiot HF, Helmig-Schurter AV, van't Noordende JM: The relevance of cultures of catheterdrawn blood and heparin-lock fluid to diagnose infection in hematologic patients. Ann Hematol 64:28-34, 1992
14. Abdelkefi A, Ben Othman T, Kammoun L, et al: Prevention of central venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patients with haematooncological disease. Thromb Haemost 92:654-661, 2004
15. Raad II, Bodey GP: Infectious complications of indwelling vascular catheters. Clin Infect Dis 15:197-208, 1992
16. van Rooden CJ, Schippers EF, Barge RM, et al: Infectious complications of central venous catheters increase the risk of catheter-related thrombosis in hematology patients: A prospective study. J Clin Oncol 23:2655-2660, 2005
17. Ray CE Jr, Shenoy SS, McCarthy PL, et al: Weekly prophylactic urokinase installation in tunneled central venous access devices. J Vasc Interv Radiol 10:1330-1334, 1999
18. Solomon B, Moore J, Arthur C, et al: Lack of efficacy of twice-weekly urokinase in the prevention of complications associated with Hickman catheters: A multicenter randomised comparison of urokinase versus heparin. Eur J Cancer 37:2379-2384, 2001
19. Xiang DZ, Verbeken EK, Van Lommel AT, et al: Composition and formation of the sleeve enveloping a central venous catheter. J Vasc Surg 28:260-271, 1998
20. O'Farrell L, Griffith JW, Lang CM: Histologic development of the sheath that forms around long-term implanted central venous catheters. JPEN J Parenter Enteral Nutr 20:156-158, 1996
21. Veenstra DL, Saint S, Saha S, et al: Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: A meta-analysis. JAMA 281:261-267, 1999
22. Abdelkefi A, Torjman L, Ladeb S, et al: Randomized trial of prevention of catheter-related bloodstream infection by continuous infusion of low-dose unfractionated heparin in patients with hematologic and oncologic disease. J Clin Oncol 23:7864-7870, 2005